A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?
about
Vaccines: the Fourth CenturyModel suggesting that replication of influenza virus is regulated by stabilization of replicative intermediatesNewcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses.Model-based design of growth-attenuated virusesComputational fitness landscape for all gene-order permutations of an RNA virus.Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines.Development of replication-competent viral vectors for HIV vaccine delivery.RNA polymerase I-driven minigenome system for Ebola viruses.Induction of interferon and interferon signaling pathways by replication of defective interfering particle RNA in cells constitutively expressing vesicular stomatitis virus replication proteinsChimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity.Thrips and tospoviruses come of age: mapping determinants of insect transmission.Rescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNAReverse genetics approaches to combat pathogenic arenavirusesReviewing Chandipura: a vesiculovirus in human epidemics.A unique strategy for mRNA cap methylation used by vesicular stomatitis virus.A seven-segmented influenza A virus expressing the influenza C virus glycoprotein HEFNewcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and catsRecombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein.Sendai virus vectors as an emerging negative-strand RNA viral vector system.Influenza virus induction of apoptosis by intrinsic and extrinsic mechanisms.Hendra and nipah infection: pathology, models and potential therapies.Role of the sonchus yellow net virus N protein in formation of nuclear viroplasmsAn adenovirus vector-mediated reverse genetics system for influenza A virus generation.Recombinant parainfluenza virus 5 (PIV5) expressing the influenza A virus hemagglutinin provides immunity in mice to influenza A virus challengeThe role of reverse genetics in the development of vaccines against respiratory viruses.Active borna disease virus polymerase complex requires a distinct nucleoprotein-to-phosphoprotein ratio but no viral X proteinMinigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever virusesDevelopment of reverse genetics systems for bluetongue virus: recovery of infectious virus from synthetic RNA transcripts.Arenavirus reverse genetics for vaccine developmentConstruction of a Sonchus Yellow Net Virus minireplicon: a step toward reverse genetic analysis of plant negative-strand RNA viruses.Influenza reverse genetics: dissecting immunity and pathogenesis.Development and applications of single-cycle infectious influenza A virus (sciIAV).Recombinant Newcastle disease virus-vectored vaccines against human and animal infectious diseases.Recovery of infectious bluetongue virus from RNA.Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response in human dendritic cells and macrophagesRescue of recombinant Newcastle disease virus: a short history of how it all started.Chimeric rabies glycoprotein with a transmembrane domain and cytoplasmic tail from Newcastle disease virus fusion protein incorporates into the Newcastle disease virion at reduced levelsEstablishment and characterization of plasmid-driven minigenome rescue systems for Nipah virus: RNA polymerase I- and T7-catalyzed generation of functional paramyxoviral RNA.Generation of measles virus with a segmented RNA genome.
P2860
Q27490454-2667C2A7-B310-4430-A7BA-D6A6A0A71CCEQ27863792-9C614445-6AB6-4DD8-A046-DEFA392831D0Q30357521-E0582E92-70C7-41B7-A50B-04AD458EDF34Q33256104-6374F261-351A-4807-AF06-CA50BBD29E78Q33406225-3D5AB4DA-D64B-452C-BBA6-98AE1F7C5D5AQ33570326-4CA03ED6-9882-4E97-A418-109B4D6F2BBAQ33694226-A15E8319-8844-4A6A-8E5C-735E84D13123Q33707432-90D89439-2A88-4DB5-9464-C1F37C1BD246Q33826779-ABDE4694-594B-4615-8BAE-A6B0C855CD99Q33908690-E056EF27-3D41-4AF1-92F7-E24B5D0182BCQ33935898-9CAF4B59-4447-4A47-8134-0E6E4E32EABAQ34301750-4506907F-CD5D-494F-9B63-94328BDEDB51Q34574914-00CD1A36-6B90-476B-87C7-CA135F5DB0BAQ34596958-7E1B4591-592F-411D-B6BC-2664BED643AAQ34645837-741D83EA-6A41-46E3-B992-AAD93CD8ED87Q34694397-7344B38F-AC73-4B37-8D05-72E52870BECFQ34775136-F759FE14-01A3-4CFC-8AB5-071825F743BDQ35140435-2DB45D97-3198-4B9D-8C9C-AED88AA68B96Q35147223-22393B21-2EFF-4AC7-BB0A-34DA83EC13B9Q35161890-773DCBFB-9ED8-4903-A616-20E71F83641AQ35213616-AD318412-BA5F-49E0-87C2-1E20AC0E3DF9Q35658146-DFB31253-BC60-452F-AE85-779FC1EEFD02Q35857537-6C7BF949-F29E-4644-BF11-08BCB08545CEQ35947953-4065857C-93EA-47FF-8588-D3A5A7D996CFQ36016500-5B2A1A7C-3F4C-43FA-BCC9-60DCEC37DED6Q36099468-1DE0F527-2313-4E9B-BBA5-68DB29127CE5Q36541036-BB026EED-50D6-4598-9D84-00DA21D948E9Q36650409-7EE22C2C-B0E1-4FD9-A6A4-7A9E7E11B211Q36845821-46B5EB32-D55F-42CB-8792-4FDB2D727A81Q37006773-703FE1A2-B6B8-4DB6-B023-6B79D806C48EQ37252971-2D0AA647-EBD5-4AE2-B5D3-1583F02CC82FQ38188084-44BDD76A-448B-4458-8245-A7C895BA369BQ38556537-854278D9-01FA-406B-9432-21E1C72DEEC2Q38559266-CD2AAF97-01EC-49F2-B78F-DCA74FD7E89AQ38918571-53765344-EE84-410E-B6A6-526608E71907Q38959283-84C44627-518F-4511-9A42-9BE4C36B8CEBQ39186172-BADD3E41-0B54-4C4F-9175-0EFC60DC3C6BQ39498475-481DCF17-1950-42BC-A528-083F4CF5C135Q40074669-57886345-393B-46B3-B64B-79CB3974D96CQ40293099-A3237126-FFD7-4D6C-ABA9-CEA4B05AB553
P2860
A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
A decade after the generation ...... d cDNA - what have we learned?
@ast
A decade after the generation ...... d cDNA - what have we learned?
@en
A decade after the generation ...... d cDNA - what have we learned?
@nl
type
label
A decade after the generation ...... d cDNA - what have we learned?
@ast
A decade after the generation ...... d cDNA - what have we learned?
@en
A decade after the generation ...... d cDNA - what have we learned?
@nl
prefLabel
A decade after the generation ...... d cDNA - what have we learned?
@ast
A decade after the generation ...... d cDNA - what have we learned?
@en
A decade after the generation ...... d cDNA - what have we learned?
@nl
P1476
A decade after the generation ...... d cDNA - what have we learned?
@en
P2093
Gabriele Neumann
Michael A Whitt
P304
P356
10.1099/0022-1317-83-11-2635
P407
P577
2002-11-01T00:00:00Z